SciSparc (NASDAQ:SPRC) Shares Up 5.7% – Still a Buy?

SciSparc Ltd. (NASDAQ:SPRC) traded up 5.7% during trading on Tuesday . The company traded as high as $0.24 and last traded at $0.24. 372,075 shares traded hands during mid-day trading, a decline of 76% from the average session volume of 1,581,137 shares. The stock had previously closed at $0.23.

SciSparc Trading Up 5.7 %

The business’s 50-day simple moving average is $0.24 and its two-hundred day simple moving average is $0.56.

Institutional Investors Weigh In On SciSparc

An institutional investor recently bought a new position in SciSparc stock. Renaissance Technologies LLC purchased a new position in SciSparc Ltd. (NASDAQ:SPRC) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 39,700 shares of the company’s stock, valued at approximately $32,000. Renaissance Technologies LLC owned 5.59% of SciSparc at the end of the most recent quarter. 25.06% of the stock is owned by institutional investors and hedge funds.

SciSparc Company Profile

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.